Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 17/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1503116 | 0.86 | GRM2 (0.61) | GRM2CYP3A4 | |
| SCHEMBL1502949 | 0.86 | GRM2 (0.61) | GRM2CYP3A4 | |
| SCHEMBL1503163 | 0.86 | GRM2 (0.61) | GRM2CYP3A4 | |
| SCHEMBL6892790 | 0.81 | GRM2 (0.45) | GRM2 | |
| SCHEMBL1503003 | 0.76 | GRM2 (0.60) | GRM2CYP3A4 | |
| SCHEMBL1502937 | 0.69 | GRM2 (0.69) | GRM2CYP3A4 | |
| SCHEMBL6890927 | 0.69 | GRM2 (0.75) | GRM2CYP3A4 | |
| SCHEMBL1503034 | 0.69 | GRM2 (0.46) | GRM2 | |
| SCHEMBL1503036 | 0.69 | GRM2 (0.63) | GRM2CYP3A4 | |
| SCHEMBL1502995 | 0.68 | GRM2 (0.60) | GRM2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011034741-A1 | IMIDAZOPYRIDIN-2-ONE DERIVATIVES | MERCK SHARP & DOHME CORP. (US) | 2011-03-24 | — | — | WO | claimed |